Open AccessAll-oral triplet combination of ixazomib, lenalidomide, and dexamethasone in newly diagnosed transplant-eligible multiple myeloma patients: final results of the phase II IFM 2013-06 study
Author(s) -
Cyrille Touzeau,
Aurore Perrot,
Murielle Roussel,
Lionel Karlin,
Lotfi Benboubker,
Caroline Jacquet,
Mohamad Mohty,
Thierry Facon,
Salomon Manier,
MarieLorraine Chrétien,
Mourad Tiab,
Cyrille Hulin,
Xavier Leleu,
Hervé Avet Loiseau,
Thomas Dejoie,
Lucie Planche,
Michel Attal,
Philippe Moreau
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2021.280394
Subject(s) - lenalidomide , ixazomib , dexamethasone , multiple myeloma , medicine , oncology , carfilzomib
Not available.